Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 14.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 20.75
  • 52 Week Low: 12.50
  • Currency: UK Pounds
  • Shares Issued: 274.82m
  • Volume: 163,993
  • Market Cap: 39.85m
  • Beta: 0.15

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 14.50p per share. In the last year Amryt Pharma's share price has ranged from 12.50p to 20.75p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -111.2% -152.0%
ROCE 171.8%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.5 2.9
Pr/Book 2.0  
Latest F'cast
Revenue 846.7% -1.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-14 n/a (2.56) (0.87)¢ n/a n/a n/a n/a 0.0%
31-Mar-15 n/a (1.87) (4.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (1.19) (2.84)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 1.35 (7.80) (4.78)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (11.72)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 13.97 (21.23) (8.65)p n/a n/a n/a n/a 0.0%
31-Dec-19 17.70 (25.91) (8.24)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Grant Funding from Irish Government for AP103 10-Dec-2018 11:30 RNS
Lojuxta to be reimbursed in France 17-Oct-2018 07:00 RNS
Interim Results 26-Sep-2018 07:00 RNS

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 14.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 20.75
52 Week Low 12.50
Volume 163,993
Shares Issued 274.82m
Market Cap 39.85m
Beta 0.15

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.65% below the market average22.65% below the market average22.65% below the market average22.65% below the market average22.65% below the market average
13.48% below the sector average13.48% below the sector average13.48% below the sector average13.48% below the sector average13.48% below the sector average
Price Trend
52.14% below the market average52.14% below the market average52.14% below the market average52.14% below the market average52.14% below the market average
51.59% below the sector average51.59% below the sector average51.59% below the sector average51.59% below the sector average51.59% below the sector average
Income Not Available
Growth
23.30% above the market average23.30% above the market average23.30% above the market average23.30% above the market average23.30% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 11-Dec-2018

Time Volume / Share Price
16:35 36,994 @ 14.50p
15:44 1,000 @ 14.30p
14:44 40,000 @ 14.67p
11:34 5,197 @ 14.30p
11:25 10,163 @ 14.67p

Amryt Pharma Key Personnel

CEO Joe Wiley
CFO Rory Nealon

Top of Page